TABLE 2.

Summary of adverse events.

	Elderly 0.2 mg/kg (N = 8)	Elderly 0.3 mg/kg (N = 8)	Elderly 0.4 mg/kg (N = 8)	Non-elderly 0.4 mg/kg (N = 8)	Total (N = 32)
—	n (%)	n (%)	n (%)	n (%)	n (%)
Total	3 (37.5)	2 (25.0)	4 (50.0)	1 (12.5)	10 (31.3)
Hyperglycemia	2 (25.0)	0 (0)	1 (12.5)	0 (0)	3 (9.4)
Hypoalbuminemia	0 (0)	0 (0)	2 (25.0)	0 (0)	2 (6.3)
Respiratory depression	0 (0)	1 (12.5)	1 (12.5)	0 (0)	2 (6.3)
Supraventricular arrhythmia	0 (0)	0 (0)	1 (12.5)	0 (0)	1 (3.1)
First degree atrioventricular block	0 (0)	0 (0)	1 (12.5)	0 (0)	1 (3.1)
Blood pressure decreased	0 (0)	1 (12.5)	1 (12.5)	0 (0)	2 (6.3)
Hematuria	1 (12.5)	0 (0)	0 (0)	0 (0)	1 (3.1)
Anemia	0 (0)	0 (0)	0 (0)	1 (12.5)	1 (3.1)

n: the subject number; %: the percentage of the AE.